What do you mean no interest in HER-Vaxx? I thought there was still two Ph2 combo trials to be run? I don’t see any licensing deals being done before those results are available to the respective BP supplying the combo drugs to the trials. I recall LC mentioning BP weren’t concerned about the results of the first Ph2 and I understood that to mean the second Ph2 involving their drug was the trial results that would be important to them. I also took it to mean that IMU wasn’t interested in doing a deal until they could determine the value of HER-Vaxx in combo as it would be worth much more if it worked even better with a combo drug.
Media Thread, page-6191
-
- There are more pages in this discussion • 8,475 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |